U.S. flag

An official website of the United States government

NM_002834.5(PTPN11):c.179G>T (p.Gly60Val) AND RASopathy

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 24, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002513672.4

Allele description [Variation Report for NM_002834.5(PTPN11):c.179G>T (p.Gly60Val)]

NM_002834.5(PTPN11):c.179G>T (p.Gly60Val)

Gene:
PTPN11:protein tyrosine phosphatase non-receptor type 11 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q24.13
Genomic location:
Preferred name:
NM_002834.5(PTPN11):c.179G>T (p.Gly60Val)
Other names:
p.G60V
HGVS:
  • NC_000012.12:g.112450359G>T
  • NG_007459.1:g.36628G>T
  • NM_001330437.2:c.179G>T
  • NM_001374625.1:c.176G>T
  • NM_002834.5:c.179G>TMANE SELECT
  • NM_080601.3:c.179G>T
  • NP_001317366.1:p.Gly60Val
  • NP_001361554.1:p.Gly59Val
  • NP_002825.3:p.Gly60Val
  • NP_542168.1:p.Gly60Val
  • LRG_614t1:c.179G>T
  • LRG_614:g.36628G>T
  • NC_000012.11:g.112888163G>T
  • NM_001330437.2:c.179G>T
  • NM_002834.3:c.179G>T
  • NM_080601.1:c.179G>T
  • Q06124:p.Gly60Val
Protein change:
G59V
Links:
UniProtKB: Q06124#VAR_015990; dbSNP: rs397507509
NCBI 1000 Genomes Browser:
rs397507509
Molecular consequence:
  • NM_001330437.2:c.179G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374625.1:c.176G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002834.5:c.179G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_080601.3:c.179G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
RASopathy
Synonyms:
rasopathies; Noonan spectrum disorder
Identifiers:
MONDO: MONDO:0021060; MedGen: C5555857

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003442010Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Feb 24, 2024)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation.

Posey JE, Harel T, Liu P, Rosenfeld JA, James RA, Coban Akdemir ZH, Walkiewicz M, Bi W, Xiao R, Ding Y, Xia F, Beaudet AL, Muzny DM, Gibbs RA, Boerwinkle E, Eng CM, Sutton VR, Shaw CA, Plon SE, Yang Y, Lupski JR.

N Engl J Med. 2017 Jan 5;376(1):21-31. doi: 10.1056/NEJMoa1516767. Epub 2016 Dec 7.

PubMed [citation]
PMID:
27959697
PMCID:
PMC5335876

Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition.

LaRochelle JR, Fodor M, Vemulapalli V, Mohseni M, Wang P, Stams T, LaMarche MJ, Chopra R, Acker MG, Blacklow SC.

Nat Commun. 2018 Oct 30;9(1):4508. doi: 10.1038/s41467-018-06823-9.

PubMed [citation]
PMID:
30375388
PMCID:
PMC6207684
See all PubMed Citations (8)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003442010.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 60 of the PTPN11 protein (p.Gly60Val). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of PTPN11-related conditions (PMID: 27959697). ClinVar contains an entry for this variant (Variation ID: 55797). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PTPN11 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects PTPN11 function (PMID: 30375388). This variant disrupts the p.Gly60 amino acid residue in PTPN11. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11992261, 16643459, 17020470, 24039098, 26817465). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 25, 2025